Marshall Wace
CRMD icon

Marshall Wace’s CorMedix CRMD Stock Holding History

Marshall Wace’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.42M Sell
502,965
-1,463,297
-74% -$10.8M ﹤0.01% 1504
2025
Q4 		$22.9M Sell
1,966,262
-1,507,232
-43% -$16.7M 0.02% 590
2025
Q3 		$40.4M Buy
3,473,494
+893,518
+35% +$10.8M 0.04% 389
2025
Q2 		$31.8M Buy
2,579,976
+2,349,451
+1,019% +$25.9M 0.04% 423
2025
Q1 		$1.42M Buy
+230,525
New +$2.39M ﹤0.01% 1623
2024
Q4 		– Sell
-161,755
Closed -$1.31M – 2637
2024
Q3 		$1.31M Buy
161,755
+9,480
+6% +$51.3K ﹤0.01% 1535
2024
Q2 		$659K Buy
152,275
+79,619
+110% +$404K ﹤0.01% 1860
2024
Q1 		$308K Sell
72,656
-390,350
-84% -$1.35M ﹤0.01% 2101
2023
Q4 		$1.74M Sell
463,006
-451,163
-49% -$1.55M ﹤0.01% 1278
2023
Q3 		$3.38M Sell
914,169
-524,709
-36% -$2.09M 0.01% 1012
2023
Q2 		$5.7M Buy
1,438,878
+1,237,479
+614% +$6.12M 0.01% 961
2023
Q1 		$834K Buy
201,399
+48,024
+31% +$196K ﹤0.01% 1899
2022
Q4 		$647K Buy
153,375
+110,298
+256% +$390K ﹤0.01% 2266
2022
Q3 		$122K Sell
43,077
-101,114
-70% -$421K ﹤0.01% 3165
2022
Q2 		$579K Buy
144,191
+110,536
+328% +$411K ﹤0.01% 2725
2022
Q1 		$184K Buy
+33,655
New +$154K ﹤0.01% 3122
2019
Q4 		– Sell
-4,552
Closed -$29K – 1753
2019
Q3 		$29K Buy
+4,552
New +$38.3K ﹤0.01% 1570

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace's CRMD Position: Q1 2026 in Review

Marshall Wace reduced its CorMedix (CRMD) stake by 74% in Q1 2026, selling an estimated $10.8M and leaving 502,965 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

Marshall Wace first reported a position in CRMD in Q3 2019 and has held it in 17 quarters since. The position peaked at $40.4M in Q3 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Marshall Wace held 502,965 shares of CorMedix worth $3.42M as of Q1 2026.
  • Marshall Wace sold 1,463,297 CorMedix shares in Q1 2026, an estimated $10.8M.
  • CorMedix made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1504 holding.
  • Marshall Wace first reported a position in CorMedix in Q3 2019 and has held it in 17 quarters since.
  • Marshall Wace's CorMedix position peaked at $40.4M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.